EP Patent

EP4173615A2 — Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems

Assigned to Taris Biomedical LLC · Expires 2023-05-03 · 3y expired

What this patent protects

Intravesical drug delivery devices (100, 500, 600) are provided which may comprise an elongated body (102, 502, 602) formed of a matrix system (524, 624) of a drug dispersed in a biocompatible polymer, the elongated body (102, 502, 602) having a first end (104), an opposed second…

USPTO Abstract

Intravesical drug delivery devices (100, 500, 600) are provided which may comprise an elongated body (102, 502, 602) formed of a matrix system (524, 624) of a drug dispersed in a biocompatible polymer, the elongated body (102, 502, 602) having a first end (104), an opposed second end (106), and an intermediate portion (108) between the first and second ends (104, 106); and an elastic retention frame (110, 510, 610) associated with the elongated body (102, 502, 602) and effective to bias the elongated body (102, 502, 602) into a coiled retention shape.

Drugs covered by this patent

Patent Metadata

Patent number
EP4173615A2
Jurisdiction
EP
Classification
—
Expires
2023-05-03
Drug substance claim
No
Drug product claim
No
Assignee
Taris Biomedical LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.